N-(4-(2-amino-6-methylpyrimidin-4-ylamino)phenyl)-4-(quinolin-4-ylamino)benzamide,
SGI-1027,
SGI-1027,
1020149-73-8,
N-(4-((2-amino-6-methylpyrimidin-4-yl)amino)phenyl)-4-(quinolin-4-ylamino)benzamide,
DNA Methyltransferase Inhibitor II,
SGI 1027,
N-[4-[(2-amino-6-methylpyrimidin-4-yl)amino]phenyl]-4-(quinolin-4-ylamino)benzamide,
CHEMBL2336409,
GTPL8891,
SCHEMBL3655385,
C27H23N7O,
AOB6458,
SGI1027,
HMS3653O06,
BCP09928,
EX-A2160,
BDBM50430056,
FD5030,
MFCD27937047,
s7276,
ZINC95591603,
AKOS024458519,
CS-2735,
SB19043,
Benzamide, N-[4-[(2-amino-6-methyl-4-pyrimidinyl)amino]phenyl]-4-(4-quinolinylamino)-,
KS-00000T67,
NCGC00381561-65,
AK175455,
BC600486,
DA-48337,
HY-13962,
FT-0755513,
SGI-1027, >=98% (HPLC),
SW220204-1,
Y1873,
A14120,
J-000537,
N-[4-[(2-Amino-6-methyl-4-pyrimidinyl)amino]phenyl]-4-(4-quinolinylamino)benzamide,
B1622,
C581203,
N-(4-(2-amino-6-methylpyrimidin-4-ylamino)phenyl)-4-(quinolin-4-ylamino)benzamide,